Directory
>
John Bothos
John Bothos
Post-Doctoral Fellow | Vividion Therapeutics, Inc.
Maryland, Gaithersburg, United States
John Bothos
Summary
John Bothos is an accomplished professional with extensive experience in clinical development and drug research, particularly in the fields of oncology and hematology. As the Vice President of Early Clinical Development at Vividion Therapeutics, he leads innovative projects that aim to advance cancer treatment. His career includes significant leadership roles at major pharmaceutical companies such as AstraZeneca, Johnson & Johnson, and GSK, where he has managed complex clinical trials and overseen drug development processes. John holds a PhD in Oncology from the University of Pennsylvania, which underpins his deep knowledge and expertise in the field. He is fluent in both English and Greek, reflecting his diverse background. With a strong focus on strategic decision-making and budget management, he has consistently delivered impactful results in his roles. His passion for advancing healthcare solutions drives his professional endeavors, making him a key player in the biotechnology sector.
John Bothos
Work Experience
Vice President, Clinical Development at
Vividion Therapeutics, Inc.
May 2023 - Present
John Bothos
Education
Rowan University, BSc, Biology
January 1995 - January 1998
University of Pennsylvania, PhD, Oncology
January 1998 - January 2004
Frequently Asked Questions about John Bothos
What is John Bothos email address?
John Bothos's primary email address is *****@vividion.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does John Bothos work for?
John Bothos is a Post-Doctoral Fellow at Vividion Therapeutics, Inc..
Where John Bothos graduated from?
John Bothos holds a degree in null from Rowan University.
How can I directly contact John Bothos?
To contact John Bothos directly, you can use the email address *****@vividion.com. Complete contact information is available upon registration with Muraena.
Who is John Bothos?
John Bothos is an accomplished professional with extensive experience in clinical development and drug research, particularly in the fields of oncology and hematology. As the Vice President of Early Clinical Development at Vividion Therapeutics, he leads innovative projects that aim to advance cancer treatment. His career includes significant leadership roles at major pharmaceutical companies such as AstraZeneca, Johnson & Johnson, and GSK, where he has managed complex clinical trials and overseen drug development processes. John holds a PhD in Oncology from the University of Pennsylvania, which underpins his deep knowledge and expertise in the field. He is fluent in both English and Greek, reflecting his diverse background. With a strong focus on strategic decision-making and budget management, he has consistently delivered impactful results in his roles. His passion for advancing healthcare solutions drives his professional endeavors, making him a key player in the biotechnology sector.
John`s contact details
*****@vividion.com
***********@astrazeneca.com
*******@medimmune.com
****@jnj.com
Colleagues
Post doctoral fellow
Scientist
Sales Attendant
Director of Technology
Chemist
Undergraduate Research Associate
Associate
Head of Market Access
Clinical Research Associate
Audit Senior III